The Greatest Healthcare Disparity: Addressing Inequities in the Treatment of Childhood Central Nervous System Tumors in Low- and Middle-Income Countries

Adv Tech Stand Neurosurg. 2023:48:1-19. doi: 10.1007/978-3-031-36785-4_1.

Abstract

The antithesis between childhood cancer survival rates in low- and middle-income countries (LMIC) and high-income countries (HIC) represents one of healthcare's most significant disparities. In HICs, the 5-year survival rate for children with cancer, including most brain tumors, exceeds 80%. Unfortunately, children in LMICs experience far worse outcomes with 5-year survival rates as low as 20%. To address inequities in the treatment of childhood cancer and disease burden globally, the World Health Organization (WHO) launched the Global Initiative for Childhood Cancer. Within this initiative, pediatric low-grade glioma (LGG) represents a unique opportunity for the neurosurgical community to directly contribute to a paradigm shift in the survival outcomes of children in LMICs, as many of these tumors can be managed with surgical resection alone. In this chapter, we discuss the burden of pediatric LGG and outline actions the neurosurgical community might consider to improve survival for children with LGG in LMICs.

Keywords: Brain tumors; Global neurosurgery; Global pediatric oncology; Health disparity; Health inequality; Low-grade glioma; Pediatric cancer; Pediatric neurosurgery.

MeSH terms

  • Brain Neoplasms* / therapy
  • Central Nervous System Neoplasms* / therapy
  • Child
  • Developing Countries
  • Glioma* / therapy
  • Healthcare Disparities
  • Humans